Schizophrenia and Bipolar Disorder

The Friedman Brain Institute at the Mount Sinai Health System offers one of the most comprehensive programs for the treatment of affective (bipolar disorder) and non-affective psychosis (schizophrenia). Our broad base of physicians, scientists, and related medical specialists offer evidence-based and innovative programs in disease diagnosis and treatment, as well as psychological and social support. Treatment programs are available for adults, adolescents, and children at:

Mount Sinai Beth Israel
The Mount Sinai Hospital
Mount Sinai Roosevelt  
Mount Sinai St. Luke's

Psychosis Research Program

Under the direction of Sophia Frangou, MD, PhD and other internationally acclaimed clinical scientists, the program uses state- of- the-art technologies in neuroimaging and cognitive neuroscience to improve our understanding of the mechanisms that lead to psychosis and to identify new treatments. Our research includes:

  • A program to develop neuroimaging tests for the diagnosis and prognosis of psychosis
  • Use of real-time Functional Magnetic Resonance Imaging (fMRI) to ameliorate persistent hallucinations
  • Development of clinical trial protocols for new treatment interventions

Our mission is to promote discovery and accelerate translation of biomedical advances into novel prevention, detection, and treatment strategies for patients suffering from psychosis.